High and low affinity receptors for human interleukin for DA cells/leukemia inhibitory factor on human cells. Molecular characterization and cellular distribution
- PMID: 1737777
High and low affinity receptors for human interleukin for DA cells/leukemia inhibitory factor on human cells. Molecular characterization and cellular distribution
Abstract
Radioiodinated recombinant human interleukin DA (HILDA)/leukemia inhibitory factor (LIF) purified from conditioned medium of Chinese hamster ovary transfected cells enabled the identification of specific receptor sites on a variety of human cell types. Using low concentrations (up to 500 pM) of the ligand iodinated at a high specific radioactivity, high affinity receptors (equilibrium dissociation constant Kd in the range of 30-100 pM) were first demonstrated. They were expressed at low levels by human peripheral blood monocytes but not by lymphocytes, NK cells, granulocytes, and platelets. The myelomonocytic cell line THP1 as well as the T lymphoma cell line HSB2 and the lymphoblastoid B cell line DAB were also receptor-negative. In contrast, most of the non-lymphoid tumoral cell lines tested, including melanomas, neuroblastomas, and carcinomas, expressed high affinity HILDA/LIF receptors at variable levels (Bmax from 20 to 600 sites/cell). The kinetics of HILDA/LIF high affinity binding to the choriocarcinoma JAR cell line were characterized at 4 degrees C with association and dissociation rate constants of k1 = 2.2 10(9) M-1 min-1 and k-1 = 0.0084 min-1, respectively, corresponding to a steady-state dissociation constant k1/k-1 = 3.8 pM. The subsequent use of higher concentrations of HILDA/LIF labeled at a lower specific radioactivity enabled the identification of a low affinity component on several cell lines (Kd in the range of 1-4 nM; Bmax from 1,000 to 5,000 sites/cell). On JAR cells, this low affinity component was characterized by association and dissociation rate constants at 4 degrees C of k1 = 7.3 10(7) M-1 min-1 and k-1 = 0.19 min-1, respectively (k-1/k1 = 2.6 nM). Affinity cross-linking of HILDA/LIF to JAR cells showed two cross-linked species under both reducing and nonreducing conditions corresponding to receptor species of 120 and 250 kDa, respectively. Whereas both bands had similar intensities under high affinity conditions, the higher band predominated under low affinity conditions. Our data suggest that the 250-kDa chain could constitute the low affinity binding component whereas the association of both 250- and 120-Da subunits would form the high affinity structure.
Similar articles
-
Leukemia inhibitory factor (LIF) and oncastsin M (OSM) high affinity binding require additional receptor subunits besides GP130 and GP190.Cytokine. 1996 Mar;8(3):197-205. doi: 10.1006/cyto.1996.0028. Cytokine. 1996. PMID: 8833034
-
Generation of monoclonal antibodies against HILDA/LIF and their use in the quantitative assay of the cytokine.Cytokine. 1993 Jan;5(1):16-23. doi: 10.1016/1043-4666(93)90019-2. Cytokine. 1993. PMID: 8485303
-
Kinetic analyses of the binding of leukemia inhibitory factor to receptor on cells and membranes and in detergent solution.J Biol Chem. 1992 May 25;267(15):10238-47. J Biol Chem. 1992. PMID: 1587813
-
Distribution and binding properties of receptors for leukaemia inhibitory factor.Ciba Found Symp. 1992;167:227-39; discussion 239-44. doi: 10.1002/9780470514269.ch14. Ciba Found Symp. 1992. PMID: 1425015 Review.
-
Reconstitution of high affinity leukaemia inhibitory factor (LIF) receptors in haemopoietic cells transfected with the cloned human LIF receptor.Ciba Found Symp. 1992;167:245-55; discussion 255-9. doi: 10.1002/9780470514269.ch15. Ciba Found Symp. 1992. PMID: 1425017 Review.
Cited by
-
Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome.Am J Hum Genet. 2004 Feb;74(2):298-305. doi: 10.1086/381715. Epub 2004 Jan 21. Am J Hum Genet. 2004. PMID: 14740318 Free PMC article.
-
Activating mechanism of CNTF and related cytokines.Mol Neurobiol. 1996 Jun;12(3):195-209. doi: 10.1007/BF02755588. Mol Neurobiol. 1996. PMID: 8884748 Review.
-
Leukemia inhibitory factor (LIF) modulates pro-opiomelanocortin (POMC) gene regulation in stably transfected AtT-20 cells overexpressing LIF.Endocrine. 1997 Dec;7(3):325-30. doi: 10.1007/BF02801326. Endocrine. 1997. PMID: 9657069
-
Characterization of a binding protein for leukemia inhibitory factor localized in extracellular matrix.J Cell Biol. 1993 Aug;122(3):713-9. doi: 10.1083/jcb.122.3.713. J Cell Biol. 1993. PMID: 8335694 Free PMC article.
-
Extensive mannose phosphorylation on leukemia inhibitory factor (LIF) controls its extracellular levels by multiple mechanisms.J Biol Chem. 2011 Jul 15;286(28):24855-64. doi: 10.1074/jbc.M111.221432. Epub 2011 May 25. J Biol Chem. 2011. PMID: 21613225 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous